Home › Companies › Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical › Mirzyme Therapeutics
Mirzyme Therapeutics
MirZyme is an innovative company focused on the development of tailored therapeutics to prevent preeclampsia and fetal growth restriction.
Operating in biopharma, biotechnology, health care, medical, pharmaceutical based in Europe, Middle East, and Africa (EMEA), Mirzyme Therapeutics was founded in 2016.
Within the biopharma, biotechnology, health care, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Seed.
The company reports a headcount in the c_00011_00050 range.
It has disclosed roughly $2.1M in funding.
| Sector | Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2016 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $2,100,000 |
Website: www.mirzyme.com
Browse related
Sign in to view the contact information we hold for Mirzyme Therapeutics.
Create a free account
Create a free account